Prostate Growth and Prevalence of Prostate Diseases in Early Onset Spinal Cord Injuries

European Urology

Volumn 56, Issue 1, 2009, Pages 142-150

  Bartoletti, Riccardo ^a   Gavazzi, Andrea ^a   Cai, Tommaso ^a   Mondaini, Nicola ^a   Morelli, Aldo ^b   Del Popolo, Giulio ^a   Geppetti, Pierangelo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

Benign prostatic hyperplasia; Prostate cancer; PSA; Serum testosterone level; Spinal cord lesion early onset

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; HISTORY OF MEDICINE; HORMONE DETERMINATION; HUMAN; INNERVATION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONSET AGE; ORGAN GROWTH; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE GROWTH; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; SPINAL CORD INJURY; TESTOSTERONE BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY; URINE CULTURE;

ADOLESCENT; ADULT; AGE OF ONSET; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES; PROSTATIC HYPERPLASIA; SPINAL CORD INJURIES; TESTOSTERONE; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 67349163603     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.01.088     Document Type: Article

References (30)

1. Frisbie J.H., Kumar S., Aguilera E.J., and Yalla S. Prostate atrophy and spinal cord lesions. Spinal Cord 44 (2006) 24-27
2. Pannek J., Berges R.R., Cubick G., Meindl R., and Senge T. Prostate size and PSA serum levels in male patients with spinal cord injury. Urology 62 (2003) 845-848
3. Konety B.R., Nguyen T.T., Brenes G., Lewis N., Saul M., Nelson J.B., et al. Evaluation of the effect of spinal cord injury on serum PSA levels. Urology 56 (2000) 82-86
4. Lynne C.M., Aballa T.C., Wang T.J., Rittenhouse H.G., Ferrell S.M., and Brackett N.L. Serum and semen prostate specific antigen concentrations are different in young spinal cord injuried men compared to normal controls. J Urol 162 (1999) 89-91
5. Wang J.M., Mc Kenna K.E., Mc Vary K.T., and Lee C. Requirement of innervation for maintenance of structural and functional integrity in the rata prostate. Biol Reprod 44 (1991) 1171-1176
6. Doggweiler R., Zermann D.H., Ishigooka M., and Schmidt R.A. Botox- induced prostatic involution. Prostate 37 (1998) 44-50
7. Thomas C.A., Chuang Y.C., Giannantoni A., and Chancellor M.B. Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms. Curr Urol Rep 7 (2006) 266-271
8. Huang H.F., Li M.T., Linsenmeyer T.A., Ottenweller J.E., Pogach L.M., and Irwin R.J. The effect of spinal cord injury on the status of messenger ribonucleic acid for TPRM 2 and androgen receptor in the prostate of the rat. J Androl 18 (1997) 250-256
9. Ho C.H., Wuermser L.A., Priebe M.M., Chiodo A.E., Scelza W.M., and Kirshblum S.C. Spinal cord injury medicine. Epidemiology and classification. Arch Phys Med Rehabil 88 Suppl. 1 (2007) S49-S53
10. Jacobsen H., Torp-Pedersen S., and Juul N. Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia. Scand J Urol Nephrol 107 (1988) 26-31
11. Boyle P., and Napalkov P. The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension. Scand J Urol Nephrol Suppl 168 (1995) 7-12
12. Batislam E., Arik A.I., Karakoc A., Uygur M.C., Germiyanoǧlu R.C., and Erol D. Effect of transurethral indwelling catheter on serum prostate-specific antigen level in benign prostatic hyperplasia. Urology 49 (1997) 50-54
13. Mazzoli S., Cai T., Rupealta V., Gavazzi A., Castricchi Pagliai R., Mondaini N., and Bartoletti R. Interleukin 8 and anti-Chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection. Eur Urol 51 (2007) 1385-1393
14. Harvey Motulsky. Intuitive Biostatistics: Choosing a statistical test. Oxford University Press Inc. 1995. http://www.graphpad.com/www/book/Choose.htm.
15. Walsh P.C. Human benign prostatic hyperplasia: etiological considerations. Prog Clin Biol Res 145 (1984) 1-25
16. Berry S.J., Coffey D.S., Walsh P.C., and Ewing L.L. The development of human benign prostatic hyperplasia with age. J Urol 132 (1984) 474-479
17. Partin A.W., Oesterling J.E., Epstein J.I., Horton R., and Walsh P.C. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 145 (1991) 405-409
18. Federman Q., Tannenbaum M., and Vereczkey Z. Reduced incidence risk of prostatic carcinoma in patients with spinal cord injury. Am J Paraplegia 16 Suppl. (1993) 280
19. Frisbie J.H. Cancer of the prostate in mielopathy patients: lower risk with higher levels of paralysis. J Spinal Cord Med 24 (2001) 92-94
20. Pramudji C.K., Mutchnik S.E., DeConcini D., and Boone T.B. Prostate cancer screening with prostate specific antigen in spinal cord injuried men. J Urol 167 (2002) 1303-1305
21. McVary K.T., Razzaq A., Lee C., Venegas M.F., Rademaker A., and McKenna K.E. Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 51 (1994) 99-107
22. Abelli L., Geppetti P., and Maggi C.A. Relative contribution of sympathetic and sensory nerves to thermal nociception and tissue trophism in rats. Neuroscience 57 (1993) 739-745
23. Dinis P., Charrua A., Avelino A., Nagy I., Quintas J., Ribau U., and Cruz F. The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate. Eur Urol 48 (2005) 162-167
24. Brady C.M., Apostolidis A.N., Harper M., Yiangou Y., Beckett A., Jacques T.S., et al. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int 93 (2004) 770-776
25. Apostolidis A., Popat R., Yiangou Y., Cockayne D., Ford A.P., Davis J.B., et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174 (2005) 977-982 discussion 982-3
26. Borodic G.E., and Acquadro M.A. The use of botulinum toxin for the treatment of chronic facial pain. J Pain 3 (2002) 21-27
27. Voller B., Sycha T., Gustorff B., Schmetterer L., Lehr S., Eichler H.G., et al. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A. Neurology 61 (2003) 940-944
28. Tugnoli V., Capone J.G., Eleopra R., Quatrale R., Sensi M., Gastaldo E., et al. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin. Pain 130 (2007) 76-83
29. Welch M.J., Purkiss J.R., and Foster K.A. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38 (2000) 245-258
30. Shim H.B., Jung T.Y., Lee J.K., and Ku J.H. Prostate activity and prostate cancer in spinal cord injury. Prostate Cancer Prostatic Dis 9 (2006) 115-120